Merrimack Pharmaceuticals, Inc.

MACK · NASDAQ
Analyze with AI
$15.15+$0.015 (+0.1%)
At close:May 17, 2024, 7:59 PM UTC
P/E TTM-183.37
P/B TTM11.55
P/S TTM0
Dividend Yield0%
EPS-$0.09
Beta1.416
Valuation
PEG Ratio-1.83
FCF Yield-0.68%
EV / EBITDA216.47
Quality
ROIC-11.73%
Gross Margin0.00%
Cash Conv. Ratio1.84
Growth
Revenue 3Y CAGR
FCF Growth12.63%
Safety
Net Debt / EBITDA-5.95
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Merrimack Pharmaceuticals, Inc. (MACK) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Merrimack Pharmaceuticals, Inc. (MACK) stock price today?

As of May 17, 2024, 7:59 PM UTC, Merrimack Pharmaceuticals, Inc. (MACK) stock is trading at $15.15. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date MACK stock quotes for informed trading decisions.

What is Merrimack Pharmaceuticals, Inc.'s market capitalization?

Merrimack Pharmaceuticals, Inc. (MACK) has a market capitalization of approximately $224.0M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Merrimack Pharmaceuticals, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the MACK stock price changes.

What is the 52-week range for Merrimack Pharmaceuticals, Inc. stock?

Merrimack Pharmaceuticals, Inc. (MACK) stock has traded in a 52-week range of $11.53 — $15.89. The 52-week range shows the highest and lowest prices at which MACK traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Merrimack Pharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does Merrimack Pharmaceuticals, Inc. stock have?

Merrimack Pharmaceuticals, Inc. (MACK) stock recently traded approximately 922.5K shares. Trading volume indicates market liquidity and investor interest in MACK. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Merrimack Pharmaceuticals, Inc. stock.

Does Merrimack Pharmaceuticals, Inc. pay dividends to shareholders?

Yes, Merrimack Pharmaceuticals, Inc. (MACK) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Merrimack Pharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Merrimack Pharmaceuticals, Inc.'s intraday price range?

Today, Merrimack Pharmaceuticals, Inc. (MACK) stock has traded in a range of $15.14 — $15.17. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring MACK's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Merrimack Pharmaceuticals, Inc. stock data?

AlphaPilot sources real-time MACK stock quotes, fundamental financial data, and historical price charts for Merrimack Pharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Merrimack Pharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of MACK stock performance.